feed,title,long_url,short_url
SeekingAlpha,Aclaris plummets as mid-stage trial for arthritis therapy fails,https://seekingalpha.com/news/4035435,
SeekingAlpha,"Auxly Cannabis GAAP EPS of C$0.03, revenue of C$28.21M; reaffirms FY23 outlook",https://seekingalpha.com/news/4035434,
SeekingAlpha,SNDL announces renewal of share repurchase program,https://seekingalpha.com/news/4035433,
